BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 27448535)

  • 1. Differences in biochemical and genetic biomarkers in patients with heart failure of various etiologies.
    Bielecka-Dabrowa A; Sakowicz A; Misztal M; von Haehling S; Ahmed A; Pietrucha T; Rysz J; Banach M
    Int J Cardiol; 2016 Oct; 221():1073-80. PubMed ID: 27448535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: A phenomics approach.
    van Essen BJ; Tharshana GN; Ouwerkerk W; Yeo PSD; Sim D; Jaufeerally F; Ong HY; Ling LH; Soon DKN; Lee SGS; Leong G; Loh SY; San Tan R; Ramachandra CJ; Hausenloy DJ; Liew OW; Chong J; Voors AA; Lam CSP; Richards AM; Tromp J
    Eur J Heart Fail; 2024 Apr; 26(4):841-850. PubMed ID: 38311963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloperoxidase, carnitine, and derivatives of reactive oxidative metabolites in heart failure with preserved versus reduced ejection fraction: A meta-analysis.
    Wong CN; Gui XY; Rabkin SW
    Int J Cardiol; 2024 Mar; 399():131657. PubMed ID: 38101703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Nitrosative/Oxidative Stress and Inflammation in Heart Failure with Preserved and Reduced Ejection Fraction.
    Momot K; Krauz K; Czarzasta K; Zarębiński M; Puchalska L; Wojciechowska M
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in proteomic correlates of coronary microvascular dysfunction among patients with heart failure and preserved ejection fraction.
    Chandramouli C; Ting TW; Tromp J; Agarwal A; Svedlund S; Saraste A; Hage C; Tan RS; Beussink-Nelson L; Lagerström Fermer M; Gan LM; Lund L; Shah SJ; Lam CSP
    Eur J Heart Fail; 2022 Apr; 24(4):681-684. PubMed ID: 35060248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative Proteomic Analysis Reveals the Cytoskeleton Regulation and Mitophagy Difference Between Ischemic Cardiomyopathy and Dilated Cardiomyopathy.
    Liu M; Zhai L; Yang Z; Li S; Liu T; Chen A; Wang L; Li Y; Li R; Li C; Tan M; Chen Z; Qian J
    Mol Cell Proteomics; 2023 Dec; 22(12):100667. PubMed ID: 37852321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart Failure with Recovered Ejection Fraction in Patients with Vinculin Loss-of-function Variants.
    Zahavich L; Akilen R; George K; Mital S
    J Cardiovasc Transl Res; 2023 Dec; 16(6):1303-1309. PubMed ID: 37548861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HBI-8000 improves heart failure with preserved ejection fraction via the TGF-β1/MAPK signalling pathway.
    Tian J; Li W; Zeng L; Li Y; Du J; Li Y; Li B; Su G
    J Cell Mol Med; 2024 Apr; 28(7):e18238. PubMed ID: 38509729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretoneurin levels are higher in dilated cardiomyopathy than in ischaemic cardiomyopathy: preliminary results.
    Plášek J; Dodulík J; Lazárová M; Stejskal D; Švagera Z; Chobolová N; Šulc P; Evin L; Purová D; Václavík J
    Front Cardiovasc Med; 2023; 10():1297900. PubMed ID: 38259301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered Expression of Intestinal Tight Junction Proteins in Heart Failure Patients with Reduced or Preserved Ejection Fraction: A Pathogenetic Mechanism of Intestinal Hyperpermeability.
    Koufou EE; Assimakopoulos SF; Bosgana P; de Lastic AL; Grypari IM; Georgopoulou GA; Antonopoulou S; Mouzaki A; Kourea HP; Thomopoulos K; Davlouros P
    Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiography-based machine learning algorithm for distinguishing ischemic cardiomyopathy from dilated cardiomyopathy.
    Zhou M; Deng Y; Liu Y; Su X; Zeng X
    BMC Cardiovasc Disord; 2023 Sep; 23(1):476. PubMed ID: 37752424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of prior myocardial infarction on outcome in patients with ischaemic HFrEF: insights from the EVIdence based TreAtment in Heart Failure (EVITA-HF) registry.
    Heer T; Zeymer U; Hochadel M; Frankenstein L; Pauschinger M; Hambrecht R; Bruder O; Böhm M; Maier LS; Zahn R; Senges J
    Clin Res Cardiol; 2024 May; ():. PubMed ID: 38717480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Overview of Diabetic Cardiomyopathy.
    Quaiyoom A; Kumar R
    Curr Diabetes Rev; 2024; 20(5):e121023222139. PubMed ID: 37842898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide association study of dilated cardiomyopathy-induced heart failure associated with renal insufficiency in a Chinese population.
    Hu Y; Jin L; Wang Z
    BMC Cardiovasc Disord; 2023 Jun; 23(1):335. PubMed ID: 37391705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced mitochondrial pyruvate carrier expression in hearts with heart failure and reduced ejection fraction patients: ischemic vs. non-ischemic origin.
    Lopez-Vazquez P; Fernandez-Caggiano M; Barge-Caballero E; Barge-Caballero G; Couto-Mallon D; Grille-Cancela Z; Blanco-Canosa P; Paniagua-Martin MJ; Enriquez-Vazquez D; Vazquez-Rodriguez JM; Domenech N; Crespo-Leiro MG
    Front Cardiovasc Med; 2024; 11():1349417. PubMed ID: 38525191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in Mitochondrial Oxidative Phosphorylation System: Relationship of Complex V and Cardiac Dysfunction in Human Heart Failure.
    Giménez-Escamilla I; Benedicto C; Pérez-Carrillo L; Delgado-Arija M; González-Torrent I; Vilchez R; Martínez-Dolz L; Portolés M; Tarazón E; Roselló-Lletí E
    Antioxidants (Basel); 2024 Feb; 13(3):. PubMed ID: 38539818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintaining Success for Patients With Dilated Cardiomyopathy and Remission of Heart Failure.
    Halliday BP; Cleland JGF
    JACC Basic Transl Sci; 2022 May; 7(5):500-503. PubMed ID: 35663636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Cardiac Computed Tomography for Etiology Evaluation of Newly Diagnosed Heart Failure with Reduced Ejection Fraction.
    Im DJ; Youn JC; Lee HJ; Nam K; Suh YJ; Hong YJ; Hur J; Kim YJ; Choi BW; Kang SM
    J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32708911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure: advanced development in genetics and epigenetics.
    Yang J; Xu WW; Hu SJ
    Biomed Res Int; 2015; 2015():352734. PubMed ID: 25949994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An advanced endothelial murine HFpEF model: eNOS is critical for angiotensin 1-7 rescue of the diabetic phenotype.
    Gheblawi M; de Oliveira AA; Williams VR; John R; Grant MB; Scholey JW; Oudit GY
    J Mol Cell Cardiol; 2022 Aug; 169():10-12. PubMed ID: 35489389
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.